Institutional members access full text with Ovid®

Share this article on:

Experimental infections with West Nile virus

Bowen, Richard Aa; Nemeth, Nicole Mb

Current Opinion in Infectious Diseases: June 2007 - Volume 20 - Issue 3 - p 293–297
doi: 10.1097/QCO.0b013e32816b5cad
Pathogenesis and immune response

Purpose of review West Nile virus emerged recently in North America as a serious human and animal pathogen. This review summarizes the use of experimental infections with West Nile virus in diverse vertebrate species that have been used to answer fundamental questions about the host response, pathogenesis of West Nile virus infection and virus evolution.

Recent findings West Nile virus has an extremely broad vertebrate host range. Infection of common species of birds has defined those with high vs. low potential to serve as amplifying hosts for the virus. In general, mammals (primates, horses, companion animals) are dead-end hosts for West Nile virus, although some circumstances (i.e. immunosuppression) may allow individuals to become capable of transmitting the virus to mosquitoes. Some mammals (rodents, rabbits, squirrels) and reptiles (alligators) have been found to develop a viremia of sufficient magnitude to predict at least low competence for infecting feeding mosquitoes. Finally, experimental infection of rodents, horses and primates with West Nile virus has been integral to developing and evaluating the efficacy of West Nile virus vaccines.

Summary Experimental infection with West Nile virus has assisted in delineating those hosts important and not important to the transmission cycle, in understanding how the virus induces disease in susceptible hosts, and in validating the efficacy of vaccines used for control of disease.

aDepartment of Biomedical Sciences, USA

bDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA

Correspondence to Richard A. Bowen, Colorado State University, 3801 West Rampart Road, Fort Collins, CO 80523, USA Tel: +1 970 491 5768; fax: +1 970 491 3557; e-mail:

© 2007 Lippincott Williams & Wilkins, Inc.